Mass treatment with IVM is an integral component of the onchocerciasis control programmes.

Historically, onchocerciasis control targeted vector breeding sites, but the current strategy relies on mass administration of a single drug, ivermectin.

Here, we argue that prophylactic and therapeutic vaccines would accelerate elimination efforts and safeguard the enormous strides made in onchocerciasis control.

This immunomic approach not only demonstrates the power of this postgenomic discovery platform but also provides additional tools for onchocerciasis control programs.

The NTD Control Programme uses the existing Onchocerciasis Control Programme as a platform and involves primary health workers.

Onchocerciasis control is considered to be one of the most successful and cost-effective public health campaigns ever launched.